(Q33855386)

29 July 2017

1 reference

title

Medical management of diabetic retinopathy: fenofibrate and ACCORD Eye studies (English)

1 reference

29 July 2017

1 reference

A D Wright

1

1 reference

PubMed ID

21436845

29 July 2017

P M Dodson

series ordinal

2

1 reference

29 July 2017

25 March 2011

1 reference

29 July 2017

1 reference

29 July 2017

25

1 reference

29 July 2017

7

1 reference

29 July 2017

843-849

1 reference

https://scigraph.springernature.com/pub.10.1038/eye.2011.62

29 July 2017

0 references

cites work

Pharmacoepidemiology safety study of fibrate and statin concomitant therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178166

Effects of medical therapies on retinopathy progression in type 2 diabetes

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178166

Fenofibrate suppresses microvascular inflammation and apoptosis through adenosine monophosphate-activated protein kinase activation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178166

Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178166

Effects of combination lipid therapy in type 2 diabetes mellitus

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178166

Effects of intensive blood-pressure control in type 2 diabetes mellitus

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178166

Effect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178166

Diabetic retinopathy and blockade of the renin-angiotensin system: new data from the DIRECT study programme

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178166

Management of diabetic retinopathy: could lipid-lowering be a worthwhile treatment modality?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178166

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178166

Management of diabetic retinopathy: a systematic review

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178166

The pathobiology of diabetic complications: a unifying mechanism

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178166

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178166

Medical treatment of diabetic retinopathy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178166

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178166

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178166

Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178166

Double-blind trial of Atromid-S in exudative diabetic retinopathy.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178166

Factors associated with avoidance of severe complications after 25 yr of IDDM. Pittsburgh Epidemiology of Diabetes Complications Study I.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3178166

Prevalence and the associated burden of illness of symptoms of diabetic peripheral neuropathy and diabetic retinopathy.

28 July 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2011.62

Ethnicity, race, and baseline retinopathy correlates in the veterans affairs diabetes trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2011.62

Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? A U.S. population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2011.62

The prevalence of diabetic retinopathy among adults in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2011.62

A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2011.62

A prospective study of serum lipids and risk of diabetic macular edema in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2011.62

Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2011.62

Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2011.62

Severe hypoglycemia and risks of vascular events and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2011.62

PPARalpha: an emerging therapeutic target in diabetic microvascular damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2011.62

Effect of fenofibrate on brachial artery flow-mediated dilatation in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2011.62

Reduction in risk of progression of diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2011.62

Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group

21 January 2018

1 reference

12 December 2020

The effect of ruboxistaurin on visual loss in patients with moderately severe to very severe nonproliferative diabetic retinopathy: initial results of the Protein Kinase C beta Inhibitor Diabetic Retinopathy Study (PKC-DRS) multicenter randomized cl

1 reference

12 December 2020

Peroxisome proliferator-activated receptor-alpha and atherosclerosis: from basic mechanisms to clinical implications

1 reference

12 December 2020

Vascular endothelial growth factor is a critical stimulus for diabetic macular edema

1 reference

12 December 2020

Fenofibrate regulates retinal endothelial cell survival through the AMPK signal transduction pathway

1 reference

12 December 2020

The importance of serum lipids in exudative diabetic macular edema in type 2 diabetic patients

1 reference

12 December 2020

1 reference

12 December 2020

A three-year trial of atromid therapy in exudative diabetic retinopathy

1 reference

12 December 2020

A double-blind controlled trial of clofibrate in the treatment of diabetic retinopathy

1 reference

12 December 2020

Retinal vascular abnormalities in the hyperlipidaemias

1 reference

12 December 2020

Images in clinical medicine. Paget's disease of the mandible

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2011.62

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/EYE.2011.62

1 reference

PubMed ID

21436845

Dimensions Publication ID

29 July 2017

1042517890

0 references

Fatcat ID

release_pvf64dc6ijewvkhqst6xei2lfe

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pvf64dc6ijewvkhqst6xei2lfe

24 November 2022

mapped directly with Wikidata item

PMCID

3178166

1 reference

29 July 2017

1 reference

PubMed ID

21436845